Stempoint Capital’s TScan Therapeutics TCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-860,951
Closed -$4.29M 70
2024
Q3
$4.29M Buy
860,951
+15,882
+2% +$79.1K 1.28% 24
2024
Q2
$4.94M Buy
+845,069
New +$4.94M 1.45% 23